0001493152-22-013998.txt : 20220516 0001493152-22-013998.hdr.sgml : 20220516 20220516174718 ACCESSION NUMBER: 0001493152-22-013998 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRANCACCIO JOHN P CENTRAL INDEX KEY: 0001276551 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41386 FILM NUMBER: 22931331 MAIL ADDRESS: STREET 1: C/O TAMIR BIOTECHNOLOGY, INC. STREET 2: 11 DEER PARK DRIVE, SUITE 204 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OKYO Pharma Ltd CENTRAL INDEX KEY: 0001849296 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA BUSINESS PHONE: 44 (0) 207 495 2379 MAIL ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA 3 1 ownership.xml X0206 3 2022-05-16 0 0001849296 OKYO Pharma Ltd OKYO 0001276551 BRANCACCIO JOHN P C/O OKYO PHARMA LIMITED MARTELLO COURT ADMIRAL PARK ST. PETER PORT Y7 GY1 3HB GUERNSEY 1 0 0 0 Option (right to buy) 0.2025 2028-08-19 Ordinary Shares 450000 D Option (right to buy) 0.0640 2031-08-31 Ordinary Shares 900000 D Option (right to buy) 0.1045 2032-01-31 Ordinary Shares 100000 D 25% will vest each year on June 10 beginning on August 20, 2020. 25% will vest each year on June 10 beginning on August 31, 2021. Vests in equal amounts over 3 years beginning on January 31, 2022. /s/ John Brancaccio 2022-05-16